Health Legislation

The decree establishes a Committee of Experts in charge of technical evaluation, whose mission is to carry out the technical evaluation of applications for registration of pharmaceutical products for human use. It also gives an opinion on the quality, safety and efficacy of pharmaceutical products for human use submitted for registration.

The decree creates the Commission Nationale du Médicament (CNM) for human use, whose mission is to validate the work of the Expert Committee responsible for the technical evaluation of applications for marketing authorization for pharmaceutical products for human use. It also gives a final opinion on marketing authorization applications; applications for renewal, extension of variation and transfer of marketing authorization; temporary suspension of marketing authorization; and proposals for definitive withdrawal of marketing authorization.

These guidelines establish an Essential Drug List of Botswana of 2012 and provide the requirements regarding the levels of availability across health care providers.

The decree establishes the pharmaceutical policy in Burkina Faso. The Pharmaceutical Policy is a national planning framework that expresses the government's vision, goals, objectives and strategic interventions for the development of the pharmaceutical sector. The policy aims to improve access to quality healthcare products, available throughout the country at a cost adapted to the population's purchasing power.

This document provides for standard treatment guidelines and the essential medicines list.

The Proclamation establishes a mandatory health insurance scheme for pensioners, employees and members of their families in Ethiopia.

The National Health Insurance Act was adopted to establish a National Health Insurance Authority to implement a National Health Insurance Scheme, establish a National Health Insurance Fund to pay for the cost of health care services to members of the Scheme, establish private health insurance schemes, and to provide for related matters.

This Law provides for the extension of the health insurance regime as established by Ordinance No 2005-006 of 29 September 2005 to other population categories such as employees of local authorities and their public establishments; employees of projects and other administrative structures benefiting from financial autonomy; persons exercising a liberal profession; employees and pensioners of the private sector, private law associations and other civil society organizations; professional journalists and private press collaborators; independent workers.

The decree revises Niger's national list of essential medicines from 2009

This Act provides for the establishment of an independent Drug and Food Control Authority in South Sudan and provide an appropriate and effective independent regulatory mechanism to control and regulate the manufacture, supply, promotion, marketing, advertising, distribution and use of drugs, poisons, chemicals, cosmetics medical devices and food for human or animal use.

This law establishes a social security system aiming at protecting the workers and their family, as well as other categories of the population against the risks and hazards inherent in work and life. This law was later amended by Law n°14-2023.

This Act regulates the conduct of clinical trials for medicinal products in Mauritius.

The Decree establishes the General Bases of the National Pharmaceutical Policy.

The Law establishes a mandatory health insurance scheme for pensioners, employees and members of their families in Ethiopia.

This Law defines the legal provisions relating to medicines, medical devices, other health products and the practice of pharmacy in the Islamic Republic of Mauritania. This Law is published in a collection of other legislative acts and can be found on page 3 of the file.

The Diploma approves the Medicines Registration Manual. The purpose of the Manual is to (a) Standardize the procedures and activities relating to the registration of medicines; (b) Clarify the doubts that professionals have encountered when interpreting the Registration Regulations; (c) Support professionals in the field in carrying out their daily activities in a standardized way; (d) Support applicants in complying with registration and post-registration procedures; (e) to make the registration process an optimized and increasingly swift process. 

The purpose of the Regulation is to define the procedures for approving pharmaceutical products for human use in the member states of the West African Economic and Monetary Union.

The Decree sets out the conditions for manufacturing and importing contraceptive products into Burkina Faso.

This document establishes a National List of Essential Medicines in the Central African Republic.

This Proclamation regulates activities in respect of food, medicine, environmental health, health professionals, health and controllable health related institutions in the country.